Considerations for the clinical use of stem cells in genitourinary regenerative medicine

doi:10.4252/wjsc.v13.i10.1480

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 10

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6153)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

279

WORD

121

HTML

3444

Figures (1-3)

288

Tables (1-4)

355

Sum=4487

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

295

Download

679

Sum=974

Publishing Process of This Article

Item

Count

Browse

280

Download

412

Sum=692

Oct 26, 2021 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Oct 26, 2021; 13(10): 1480-1512
Published online Oct 26, 2021. doi: 10.4252/wjsc.v13.i10.1480

Full Size Figure Download Figure

Figure 3 Stem cells from adipose tissue in regenerative medicine. A: Extraction of the stromal vascular fraction from adipose tissue and obtention of adipose-derived stromal/stem cells (ASCs) after cell culture. Ceiling culture of mature adipocytes and resulting populations of dedifferentiated fat (DFAT) cells; B: Potential uses of ASCs and/or DFAT cell-based therapies in genitourinary regenerative medicine. SVF: Stromal vascular fraction; ASC: Adipose-derived stromal/stem cells; DFAT: Dedifferentiated fat.

Citation: Caneparo C, Sorroza-Martinez L, Chabaud S, Fradette J, Bolduc S. Considerations for the clinical use of stem cells in genitourinary regenerative medicine. World J Stem Cells 2021; 13(10): 1480-1512
URL: https://www.wjgnet.com/1948-0210/full/v13/i10/1480.htm
DOI: https://dx.doi.org/10.4252/wjsc.v13.i10.1480